Nötrofil-Lenfosit Oranı Vasküler Behçet Hastalığı için Yeni Bir Belirteç Olabilir mi?
Öz
Anahtar Kelimeler
Kaynakça
- 1. Yazici H, Seyahi E, Hatemi G, et al. Behçet syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14(2):107-119 2. Balkarli A, Kucuk A, Babur H, et al. Neutrophil/lymphocyte ratio and mean platelet volume in Behçet's disease. Eur Rev Med Pharmacol Sci. 2016;20(14):3045-50 3. Zeb A, Khurshid S, Bano S, et al. The Role of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Markers of Disease Activity in Ankylosing Spondylitis. Cureus. 2019 Oct 29;11(10):e6025. doi: 10.7759/cureus.6025. 4. Bilen Y, Cankaya E, Bilen N, et al. Increased neutrophil to lymphocyte ratio (NLR) is a sign of disease activity in systemic lupus erythematosus patients with renal involvement. Nephrol Dial Transplant. 2015, 30:435-40. 5. Fu H, Qin B, Hu Z, et al.: Neutrophil-and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin Lab. 2015; 61:269-73 6. International Study Group for Behcet’s disease. Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s disease. Lancet 1990; 335:1078–1080 7. Bhakta BB, Brennan P, James TE, et al. Behçet's disease: evaluation of a new instrument to measure clinical activity. Rheumatology (Oxford). 1999 Aug;38(8):728-33 8. Hammad M, Shehata OZ, Abdel-Latif SM, et al. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet's disease: which and when to use? Clin Rheumatol. 2018 Oct;37(10):2811-2817. doi: 10.1007/s10067-018-4194-z
Ayrıntılar
Birincil Dil
Türkçe
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Nazife Bilge
*
0000-0002-0783-1072
Türkiye
Muzaffer Bilgin
0000-0002-6072-6466
Türkiye
Timuçin Kaşifoğlu
0000-0002-9941-5884
Türkiye
Yayımlanma Tarihi
20 Ocak 2021
Gönderilme Tarihi
11 Mayıs 2020
Kabul Tarihi
15 Haziran 2020
Yayımlandığı Sayı
Yıl 2021 Cilt: 43 Sayı: 1